Mission
BactiVax (anti-Bacterial Innovative Vaccines) is a European Training Network funded by the European Commission under the Marie Skłodowska-Curie Actions. BactiVax will provide high-level training in vaccinology to a new generation of 15 high-achieving, early-stage researchers. The programme brings together 14 world-class experts in vaccinology from 8 European countries to investigate complementary facets of vaccine research and development. The common goal of BactiVax is to develop effective vaccines against challenging antimicrobial-resistant bacterial infections. For more details about our research and aims see here.
PROJECT FACTS
Grant agreement number 860325
48 months duration
14 Principal Investigators
12 Beneficiaries
€4,009,373 EU contribution
Start date 1 October 2019
15 Early Stage Researchers
9 Countries
April has been a busy month for our early stage researchers
Have you ever had an infection in your ear, lung or anywhere else, that seemed so easy to treat
In November 2021 I travelled to Bilbao to complete my first planned secondment of the PhD
The human microbiota is a community of microorganisms living on or in a human being. What does this actually mean?
Vaccines undergo long and careful review to ensure safety and effectiveness before they are recommended
A continuous epic fight against bacteria, viruses and other nasty creatures nature is throwing at us
Adjuvants are vaccine components which improve the immunogenicity and protective efficacy of the antigen